Hadassah’s Wohl Institute Provides Tools for Researchers to Advance

by

Just six months have passed since the Wohl Institute for Translational Medicine opened at Hadassah Hospital Ein Kerem, but it has already become the focus of 30 research projects from Hadassah.

“In such a short time, with nearly half of it dominated by COVID-19, we’ve established ourselves as a national centre,” says Institute Director Prof. Rinat Abramovitch, Ph.D.

Lone researchers, previously stymied by the unaffordability of sophisticated imaging equipment, can now use the Wohl facilities, made possible by funds from the United Kingdom-based Wohl Legacy, a gift facilitated by Hadassah United Kingdom.

24th October 2019 – from left, HMO Director General Zeev Rotstein,
Legacy Trustees Dr. David Latchman and Ella Latchman, sister of the late Maurice Wohl.
Photo credit to Avi Hayun

Wohl Institute researchers are already publishing in scientific journals. For example, a research team that includes Hadassah nephrologists has an article on microRNA in chronic kidney disease in the Journal of the Federation of European Biochemical Societies. In another example, Emma Hajaj, an MD-PhD candidate at Hadassah’s Sharett Institute of Oncology, published a paper in the medical journal ELife after she and her team found a way to make immunotherapy more successful for melanoma patients.

Read more about the Wohl Institute.


About the Author



DONATE NOW

Donate

£

Please enter above the amount you would like to donate

Personal Info

25% more with Gift Aid
Billing Details

Donation Total: £25.00

Contact Us

Hadassah UK
25 The Burroughs
Hendon, London
NW4 4AR
Tel: 0208 202 2860
Email: uk.office(at)hadassah.org.uk
Registered Charity No. 1040848
Terms, Conditions and Policies

Check us out on Facebook